HomePress-release

Redding, California - July 24, 2024

Immunohistochemistry Market to be Worth $4.08 Billion by 2031

Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User - Global Forecast to 2031

Meticulous Research^®—a leading global market research company, published a research report titled Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User—Global Forecast to 2031.

According to this latest publication from Meticulous Research^®, the global immunohistochemistry market is estimated to reach $4.08 billion by 2031 at a CAGR of 7.2% from 2024 to 2031.The growth of this market can be attributed to various factors, such as the rising prevalence of chronic diseases coupled with the increasing geriatric population, increasing focus on rare diseases, rising awareness regarding early disease diagnosis, increasing R&D expenditure, growing demand for drug discovery & development, rising prevalence of infectious diseases, and the rise in healthcare expenditure.

Furthermore, increasing inclination towards personalized medicine, advancements in genomics and proteomics, and increasing automation in immunohistochemistry are expected to offer growth opportunities. However, stringent technical requirements, regulatory processes, and the availability of alternative technology are major hindrances to the market’s growth.

Key Players

The key players operating in the global immunohistochemistry market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC. (U.S.), Bio-Genex Laboratories (U.S.), CANDOR Bioscience GmbH (Germany), and Innovex Biosciences Inc. (U.S.).

Immunohistochemistry Market: Future Outlook

The global immunohistochemistry market is segmented by Offering (Consumables [Reagents {Fixation Reagents, Antigen Retrieval, Buffers, Blocking Reagents, Antibodies, Control Reagents, Chromogenic Substrates, and Counterstain}, and Other Accessories], Equipment [Staining System, Imaging Systems, Slide Scanners, and Tissue Microarrays], and Services & Software), Method (Avidin-Biotin Complex, Polymer-Based Immunohistochemistry, Catalyzed Signal Amplification (CSA), Fluorescyl-tyramide Amplification, Improved Catalyzed Signal Amplification (iCSA), Multi-Staining Immunohistochemistry, Labeled Streptavidin Biotin (LSAB), and PAP Method), Process (Sample Preparation, Antigen Retrieval, Background Blocking, Target Detection, and Sample Visualization), Application (Research Applications [Drug Discovery, Agriculture & Animal Research, and Other Applications], and Clinical Applications [Reproductive Health, Oncology, Infectious Disease and Other Clinical Applications]), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic Institutes & Research Centers, and Other End Users), and Geography. This study also evaluates industry competitors and analyzes the market at the global and regional levels.

Among all the offerings studied in this report, in 2024, the consumables segment is expected to account for the largest share of the immunohistochemistry market. This segment is further categorized into reagents, kits, and other accessories. The large market share of this segment is attributed to the advancements in IHC consumables, advantages offered by IHC kits and reagents such as reduced time between sample analysis & results, improved access to advanced IHC solutions, and recurring use of consumables are contributing to the large share of the segment.

Among all the methods studied in this report, in 2024, the avidin-biotin complex segment is expected to account for the largest share of the immunohistochemistry market. The large market share of this segment is attributed to various factors, which include advantages such as it can be labeled with peroxidase and its high affinity for biotin, resistivity to enzymatic reactions, and PH changes.

Among all the applications studied in this report, in 2024, the clinical applications segment is expected to account for the largest share of the immunohistochemistry market. The clinical application segment is further sub-segmented into reproductive health, oncology, and infectious disease. The large share of the segment is attributed to the increasing prevalence of chronic diseases, growing awareness regarding early disease diagnosis, and increasing affordability among hospitals and diagnostic laboratories for advanced IHC solutions.

Among all the end users studied in this report, in 2024, the hospitals & diagnostic laboratories segment is expected to account for the largest share of the immunohistochemistry market. The increasing expansion of public & private hospitals, and rising number of healthcare facilities in emerging countries, the availability of well-equipped systems, and the presence of skilled professionals in hospitals & diagnostic laboratories are the factors contributing to the large market share of the segment.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa.

Among all regions studied in this report, Asia-Pacific is expected to register the highest CAGR during the forecast period. The growth of this region is attributed to the emerging healthcare landscape, rapid urbanization, rise in the need to manage the growing burden of infectious diseases, accelerated economics in various countries of the Asia-Pacific region, have increased investments to enhance the accessibility to healthcare facilities and build better healthcare infrastructure.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5967

Key questions answered in the report:

Which are the high-growth market segments in terms of offerings, method, application, end user, and region/country?
What was the historical market size for immunohistochemistry globally?
What are the market forecasts and estimates for the period 2024–2031?
What are the major drivers, restraints, challenges, opportunities, and trends in the immunohistochemistry market?
Who are the major players in the global immunohistochemistry market?
What is the competitive landscape like, and who are the market leaders in the global immunohistochemistry market?
What are the recent developments in the global immunohistochemistry market?
What are the different strategies adopted by the major players in the global immunohistochemistry market?
What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Redding, California - July 24, 2024

Immunohistochemistry Market to be Worth $4.08 Billion by 2031

Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User - Global Forecast to 2031

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies